1-(4-Nitrophenylethyl)piperidylidene-2-(4-chlorophenyl)sulfonamide
Systematic (IUPAC) name | |
---|---|
(NE)-4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene]benzenesulfonamide | |
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 93101-02-1 |
PubChem | CID 13373555 |
ChemSpider | 10544260 |
Synonyms | W-18 |
Chemical data | |
Formula | C19H20ClN3O4S |
Molar mass | 421.91 g/mol |
| |
| |
Physical data | |
Melting point | 157 to 158 °C (315 to 316 °F) |
(what is this?) (verify) |
1-(4-Nitrophenylethyl)piperidylidene-2-(4-chlorophenyl)sulfonamide (W-18) is a potent μ-opioid agonist with a distinctive chemical structure which is not closely related to other established families of opioid drugs. It was invented by the chemists Edward Knaus, Brent Warran and Theodore Ondrus in 1981.[1]
W-18 was detected in a lab in Calgary by Canadian police.[2]
Legal status
W-18 is illegal in Sweden as of 26 January 2016.[3]
See also
- W-15
References
- ↑ Edward E. Knaus, Brent K. Warren, Theodore A. Ondrus (28 August 1984). "Patent US 4468403 - Analgesic substituted piperidylidene-2-sulfon(cyan)amide derivatives".
- ↑ "New drug W-18 ‘100 times more powerful than fentanyl’: Calgary police". Globalnews.ca. 28 January 2016. Retrieved 30 January 2016.
- ↑ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.
This article is issued from Wikipedia - version of the Friday, February 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.